$Precigen (PGEN.US)$Revenue declined continuously for five y...
$Precigen (PGEN.US)$Revenue declined continuously for five years to 0.09 billion in 2019, then only increased to 0.1 billion by 2021, with operating profit losses gradually narrowing to 0.08 billion and net income losses shrinking to 0.09 billion.
Revenue further declined by 68% to 0.025 billion in the first three quarters of 2022, with operating profit losses narrowing to 0.053 billion, and due to a 0.1 billion profit from discontinued operations, net income reached 0.05 billion.
Although the TTM P/E ratio is 17, the net income comes from discontinued operations, making it unsustainable and currently not worth investing in.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
